Phio Pharmaceuticals Corp (PHIO) Operating income 2016–2025
Phio Pharmaceuticals Corp (PHIO) annual operating income history from SEC filings — each fiscal year as reported.
-$9.2MFY2025 · since FY2016: -$9.0M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | -24.8% |
| FY2024 | -$7.4M | +31.8% |
| FY2023 | -$10.8M | +5.6% |
| FY2022 | -$11.5M | +15.2% |
| FY2021 | -$13.5M | -53.7% |
| FY2020 | -$8.8M | +2.2% |
| FY2019 | -$9.0M | -22.0% |
| FY2018 | -$7.4M | +47.6% |
| FY2017 | -$14.1M | -56.0% |
| FY2016 | -$9.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice